Previous 10 | Next 10 |
SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021 Canada NewsWire Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS ...
Generation Investment Management’s 13F portfolio value decreased from $24.11B to $24.05B this quarter. They increased Alibaba Group Holding, Intel, MercadoLibre, and Huazhu Group while reducing Cisco Systems, Equifax, Texas Instruments and Cognizant. The top three positions...
SOPHiA GENETICS SA (SOPH) Q3 2021 Earnings Conference Call November 10, 2021 08:30 ET Company Participants Jurgi Camblong - Co-Founder & Chief Executive Officer Lara Hashimoto - Chief Business Officer Ross Muken - Chief Financial Officer Philippe Menu - Chief Medical Officer Conference Ca...
Image source: The Motley Fool. Sophia Genetics SA (NASDAQ: SOPH) Q3 2021 Earnings Call Nov 10, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Sophia Genetics SA (SOPH) Q3 2021 Earnings Call Transcript
SOPHiA Genetics (NASDAQ:SOPH): Q3 Non-GAAP EPS of -$0.30 beats by $0.07; GAAP EPS of -$0.35 beats by $0.01. Revenue of $10.36M (+44.5% Y/Y) beats by $0.46M. Press Release For further details see: SOPHiA Genetics EPS beats by $0.07, beats on revenue
BOSTON and LAUSANNE, Switzerland, Nov. 10, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. Recent Highlights Revenue was $10.4 million for the third quarter, representing a 45% incre...
SOPHiA GENETICS Launches SOPHiA DDM™ for SureSelect Human All Exon v8 Canada NewsWire New bioinformatic workflow advances analysis capabilities for whole exome assessment and interpretation BOSTON and LAUSANNE, Switzerland, Nov. 1, 202...
BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor conferences: Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, Novemb...
BOSTON and LAUSANNE, Switzerland, Oct. 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market open on Wednesday, November 10, 2021. The company’s management will webcast a correspondi...
SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseases SOPHiA Clinical Exome Solution v3 offers a streamlined end-to-end workflow to facilitate the assessment of challenging Mendelian disorders PR Newswire BOSTON and ...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...